- Researchers study the risk of dementia in older adults.
- They look at a gene called APOE ε4, a variant.
- They also study damage in small brain blood vessels.
- This damage appears as white matter hyperintensities on scans.
- People who have both problems have a higher dementia risk.
- Each problem adds its own part of the risk.
- Controlling blood pressure and diabetes can help prevent damage.
- Having the APOE ε4 gene does not mean dementia.
Difficult words
- researcher — person who studies topics and collects dataResearchers
- risk — chance of something bad happening
- gene — part of the body that gives traits
- variant — a different form of something
- dementia — illness that affects memory and thinking
- damage — harm or injury to a person or thing
- blood vessel — tube in the body that carries bloodblood vessels
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you check your blood pressure?
- Do you know what a gene is?
- Would you see a doctor if you had memory problems?
Related articles
Forest loss in tropics raises local heat and deaths
A study using satellite data found that tropical deforestation from 2001–2020 exposed 345 million people to local warming and likely caused about 28,000 heat-related deaths per year, mainly in Africa, Southeast Asia and Latin America.
Study warns of heavier rain and hotter nights in Tanzania
New research warns parts of Tanzania will see more extreme rainfall and rising temperatures. Experts say farmers, health and cities will be affected and call for stronger national policies, preparedness and community climate finance.
Calorie restriction improves muscle insulin response in old rats
In 24-month-old rats, eating 35% less for eight weeks changed many muscle proteins and improved insulin-stimulated glucose uptake. Males and females showed different molecular responses, and two proteins may be targets for diabetes treatment.
Engineered antibodies could block cytomegalovirus
A research team created changed antibodies that stop human cytomegalovirus from disabling immune responses. Lab tests show the antibodies reduce virus spread, but researchers say more testing is needed before they can be used in people.